Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Biodesix, Inc.
< Previous
1
2
Next >
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
April 09, 2024
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
April 05, 2024
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
March 25, 2024
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
March 01, 2024
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
February 26, 2024
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
February 16, 2024
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
November 14, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Participate in Two Upcoming Investor Conferences in November
November 09, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces Third Quarter 2023 Results and Highlights
November 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
October 24, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting
October 03, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
September 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Participate in Two Upcoming Investor Conferences in September
September 05, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer
August 22, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces Second Quarter 2023 Results and Highlights
August 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
August 01, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023
July 24, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
July 12, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services
July 06, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier
June 27, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting
June 01, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Participate in William Blair’s 43rd Annual Growth Stock Conference
May 31, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces Four Presentations of Health Economic Data Highlighting Cost Saving Potential of Nodify Lung® Testing
May 25, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix, Inc. Chief Financial Officer Robin Harper Cowie Appointed to Colorado BioScience Association's Board of Directors
May 24, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces New Clinical Utility Evidence for the Nodify XL2® Nodule Risk Assessment Test to Be Presented at ATS 2023 International Conference
May 18, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces First Quarter 2023 Results and Highlights
May 11, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023
April 27, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix Announces Fourth Quarter and Fiscal Year End 2022 Results and Highlights
March 06, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Participate at Cowen’s 43rd Annual Healthcare Conference
February 28, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
Biodesix to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023
February 21, 2023
From
Biodesix, Inc.
Via
Business Wire
Tickers
BDSX
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.